From Discovery to First Patient: How Can We Move Faster? Part 2

The second part will look at the technologies and approaches that could transform development timelines, including New Approach Methodologies (NAMs), advanced preclinical models, AI, data-driven tools and predictive technologies. The discussion will examine not only their potential to improve decision-making and reduce development time, but also the conditions required for their broader adoption in Belgium. Overall, the session aims to identify practical levers to reduce time, risk and fragmentation between discovery and clinical translation, and to highlight where Belgium could strengthen its capabilities to remain competitive in advanced therapies.